During the past decade, UNC Diabetes Care Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UNC Diabetes Care Center" #1 sponsor was "AstraZeneca" with 5 trials, followed by "Exsulin Corporation" with 2 trials sponsored, "Andromeda Biotech Ltd." with 1 trials sponsored, "GRADE Study Group" with 1 trials sponsored and "HealthPartners Institute" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UNC Diabetes Care Center" #1 collaborator was "Amylin Pharmaceuticals, LLC." with 1 trials as a collaborator, "Becton, Dickinson and Company" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Centers for Disease Control and Prevention" with 1 trials as a collaborator and "Juvenile Diabetes Research Foundation" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "UNC Diabetes Care Center" are "Diabetes Mellitus, Non-Insulin-Dependent" (3 trials), "Type 2 Diabetes" (3 trials), "Diabetes Mellitus, Insulin-Dependent" (2 trials), "Diabetes Mellitus, Type 1" (2 trials) and "Type 1 Diabetes Mellitus" (2 trials). Many other conditions were trialed in "UNC Diabetes Care Center" in a lesser frequency.

Most popular intervention types in "UNC Diabetes Care Center" are "Drug" (10 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "AC2993" (4 trials), "INGAP-Peptide" (2 trials), "placebo" (2 trials) and "DPP-4 inhibitor (sitagliptin)" (1 trials). Other intervention names were less common.

The vast majority of trials in "UNC Diabetes Care Center" are 13 trials for "All" genders.

Currently, there are NaN active trials in "UNC Diabetes Care Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in UNC Diabetes Care Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UNC Diabetes Care Center, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".